"Biomedical Technology" has been completely reprinted after it was acquired by China Technology. Zhang Sheng, who became the head of the journal, changed it to an AB version of the journal after obtaining Zhou Xiao's consent.

As in the past, A-version journals continue to make money and publish papers that spend money to publish.

After all, there are so many people who want to raise journals and magazines, it’s not okay to have bad money!

Origin Technology only gave Zhang Sheng 3 million Soft Girl coins to maintain the operation of the magazine. This amount of money is not much or too much, and it mainly depends on the journal to make blood.

Issue B is attached to Issue A, sometimes sometimes not.

Journal B is an important academic paper on Origin Science and Technology. If others are willing to contribute and are of high quality papers, Journal B will also be published.

Excellent papers are not available in every issue, and Origin Technology cannot have important research results every month, so the publication time of B issue is not stable.

"Biomedical Technology" has published papers on "Symbiosis Protein" and "Digestible Bacteria". Even though the entire journal is still relatively garbage, it has become an important academic journal that major universities and research institutions have to subscribe to.

Zhang Sheng is also a business genius. After most universities order "Bio-medical technology", he can publicize "Bio-medical technology" to the outside world, and many universities must recognize it. This kind of publicity will allow more people to spend money to publish papers in "Bio-medical technology", and magazines will also have more opportunities to make money.

Under such circumstances, "Biomedical Technology" was sold out! Those manuscripts that spent money and waited for the paper were scheduled for a few months.

This is the first time since the founding of "Biomedical Technology"!

When will "Biomedical Technology" completely eliminate Class A journals? Just wait for the number of papers in Class B journals to increase.

"Bio-medical Technology" B published "Gasitic Bacteria Can Completely Replace the Digestive System in the Human Body". This paper is actually considered the subdivision and deepening of the first article "Gasitic Bacteria", but it is of great significance to biology and clinical medicine.

The paper describes in detail the complete experiment with mice and the effects after the experiment.

Whether it is the process or data, it is enough to support that "Digestible bacteria can completely replace the digestive system in the human body" will cause a sensation in the biology and medical circles.

This time, professors from Shuimu University, Xiaguo University of Science and Technology and other universities did not miss "Digestible bacteria can completely replace the digestive system in the human body."

Professor Li Yude, who just came back from Jiangcheng and was still complaining that China Origin Technology did not give cooperation opportunities, felt uncomfortable after seeing China Origin Technology's latest paper.

Li Yude told other professors in the college: "Shuimu University missed an opportunity! This paper means that humans have reached a new level of use of natural organisms!"

Li Yude regrets very much why he didn’t see the paper earlier and cooperated with Zhiyuan Technology earlier.

He nagged: "Why did Origin Technology hand over such an important technical cooperation to a second-rate university? We missed an important opportunity!"

Li Yude's colleague said: "Don't you know that Jiangcheng University of Technology seems to be the alma mater of Zhou Xiao, the founder of Origin Technology?"

Li Yude was stunned for a moment, obviously not knowing the news, but he said: "How easy is this alma mater? If Zhou Xiao wants to, he can study for a doctorate at Shuimu University!"

It is definitely not easy to take the doctoral exam at Shuimu University, but it may not be necessary to get it.

Li Yude lamented that if he obtained the qualification to cooperate with China Technology, Shuimu University might be both biological and medical.

This time, China Origin Technology's bold scientific research innovation has also caused a lot of controversy in the academic community of Xiaguo.

When Origin Technology developed symbiotic proteins, it was criticized, and this time it stimulated the nerves of relevant personnel.

Some big Vs forwarded some university professors' comments on the latest experimental results of Origin Technology.

"I have already commented on the symbiotic protein when China Origin Technology was developing it. Their experiments completely violated human ethics and medical ethics! Just implant symbiotic proteins on the human body, but this time it was implanted in the bionic digestive system. Is it still human? "

"I firmly oppose Origin Technology's use of the paper results this time in clinical experiments. This experiment violates ethics!?"

I don’t know who posted the rough paper “Digestible bacteria can completely replace the digestive system in the human body” online and named it the thriller title “Transforming Humans”.

The Internet spread very quickly, and the news that technology transformed the human digestive system was soon reported by major media.

The fat little white mouse Erpin in the paper published by Origin Technology has also become a standard picture.

If the Internet message is just spread like this, it is still objective and fair, but the second and third pictures are a bit rhythmic. One picture is a huge and terrifying mouse in the movie "Rat Cannibal City", and the other is a photo of a biochemical man with pus flowing all over his body.

This point is very obvious, and it is believed that the laboratory of Origin Technology is immoral.

Zhou Xiao also saw this report when he browsing Weibo and laughed it off.

He said: "With the rise of Xia Kingdom, the domestic public opinion environment is quite complex. You will never know whether the person who posted on Weibo is a human or a ghost. Even if he is a human, you will not know whether his white heart or a yellow heart. I think all scientific research that is good for the development of biomedical science and the benefits of patients. If there is no debate in scientific research, there will be no scientific research."

Zhou Xiao has a good attitude, but Mo Li is so angry.

Those experts and big Vs on Weibo are so cheerful, only caring about their own mouths. If you want to criticize you, they will never know that Mo Li and others have been in seclusion in the laboratory for a year. Of course, they cannot see the efforts of scientific researchers to explore the unknown of human beings all night long, and they cannot see the significance of such results to the progress of medicine and biology. They can only see the value of fans and immediate benefits.

Mo Li said angrily: "We just quietly completed the scientific experiment. The laboratory is not in the entertainment industry. Can't these people find something to do?"

Zhou Xiao comforted and said, "Maybe we have hurt someone's interests, so the articles that should have been published in the journal will appear on Weibo. But we don't care. Origin Technology is not a soft girl coins, so everyone can't like it."

Zhou Xiao said this with enough confidence. The development of technology is an irreversible historical rule, and no one can stop it, let alone Weibo's saliva.

Those who post tweeting ulterior motives may hope to prevent Origin Technology from applying relevant digestive bacteria to clinical practice, but not everyone is a fool, following Weibo to lead the rhythm.

Zhongshan Hospital, Futa University, Shanghai Stock Exchange, invited the Biological and Medical Laboratory of Origin Science and Technology to the Shanghai Stock Exchange with great sincerity, and placed the clinical application of digestive bacteria in Zhongshan Hospital.

Zhongshan Hospital ranks among the top in the country in the country and also gathers a large number of patients with serious gastrointestinal diseases.

The probability of rapid approval is very high when applying for clinical experiments in the name of Futan University and Zhiyuan Technology.
Chapter completed!